Clinical Trial Update: Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on iSPASM exploring induced suppression of platelet activity for aneurysmal subarachnoid hemorrhage management; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Subarachnoid Hemorrhage

Snippet

Sponsor: David Hasan | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-04